Zhitong Finance App News, Yifan Pharmaceutical (002019.SZ) issued an announcement. On November 4, 2026, Hefei Yifan Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Acceptance” issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) for registration and marketing of vinblastine sulfate injection domestically produced drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.